powerpoint presentation slides on leprosy

Got any suggestions?

We want to hear from you! Send us a message and help improve Slidesgo

Top searches

Trending searches

35 templates

biochemistry

38 templates

hispanic heritage month

21 templates

travel itinerary

46 templates

mid autumn festival

18 templates

63 templates

World Leprosy Day

It seems that you like this template, world leprosy day presentation, free google slides theme, powerpoint template, and canva presentation template.

Get creative with this new template we're releasing today and raise awareness about Hansen's disease, also called leprosy. It's one of the oldest diseases known by humans and there are treatments that can cure it, but it's still a serious disease with catastrophic consequences for the affected. We have used some illustrations, some wavy shapes on the backgrounds and other abstract elements that are slightly influenced by the Memphis graphic style. Prepare a slideshow for World Leprosy Day!

Features of this template

• 100% editable and easy to modify
• 35 different slides to impress your audience
• Contains easy-to-edit graphics such as graphs, maps, tables, timelines and mockups
• Includes 500+ icons and Flaticon’s extension for customizing your slides
• Designed to be used in Google Slides, Canva, and Microsoft PowerPoint
• 16:9 widescreen format suitable for all types of screens
• Includes information about fonts, colors, and credits of the resources used

How can I use the template?

Am I free to use the templates?

How to attribute?

Attribution required If you are a free user, you must attribute Slidesgo by keeping the slide where the credits appear. How to attribute?

Register for free and start downloading now

Related posts on our blog.

How to Add, Duplicate, Move, Delete or Hide Slides in Google Slides

How to Change Layouts in PowerPoint

How to Change the Slide Size in Google Slides

Related presentations.

Premium template

Unlock this template and gain unlimited access

• My presentations

Auth with social network:

Download presentation

We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!

Presentation is loading. Please wait.

Published by Candice French Modified over 6 years ago

Similar presentations

Presentation on theme: "LEPROSY."— Presentation transcript:

LEPROSY. A chronic contagious disease primarily affecting the peripheral nerves secondarily involving skin, mucosa of mouth and upper.

aerobic.,AFB, NO Gram stain, 60% Lipid GT=8-24 hrs

TUBERCULOSIS This is the prompt slide for the TB Therapy section.

Leprosy Leprosy (Hansen s disease ) is caused by the acid- fast bacillus Mycobacterium leprae.Unlike other mycobacteria, it does not grow in artificial.

TUBERCULOSIS Pulmonary TB.

Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs

NATIONAL HANSEN’S DISEASE PROGRAMS. DIAGNOSIS & TREATMENT OF HANSEN’S DISEASE DIAGNOSIS & TREATMENT OF HANSEN’S DISEASE.

ANTIMYCOBACTERIAL AGENTS

NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM.

HANSEN’S DISEASE. Epidemiology 1.25 cases per 10,000 persons India accounts for 80% of cases Brazil, Indonesia, Myanmar, Madagascar and Nepal endemic.

Leprosy. definition ： A chronic infectious disease caused by mycobacterium leprae, With neurologic and cutaneous lesions.

 TUBERCULOSIS.  TB is an ancient infectious disease caused by Mycobacterium tuberculosis. It has been known since 1000 B.C., so it not a new disease.

Module 2: TREATMENT.

Pulmonary TB. BY PROF. AZZA ELMedany Dr. Ishfaq Bukhari.

Leprosy (Hansen’s Disease)

 Leprosy, caused by mycobacterium leprae, has been considered incurable since ages and bears a social stigma.  Due to availability of effective antileprotic.

Antimycobacterial drugs Tuberculosis Treatment of mycobacterial infections is complicated due: Limited information regarding antimycobacterial drug actions.

LEPROSY Caused by bacterium Patients are classified into infectious or noninfectious on the basis of the type and duration of disease and effects of therapy.

Dr. Sarah Zahid PHARMACOLOGICAL MANAGEMENT OF IRON DEFICIENCY ANEMIA.

Leprosy Dr.Mohamed Shekhani. Who is at risk? web/pages/leprosy/images/girl.

About project

© 2024 SlidePlayer.com Inc. All rights reserved.

• Preferences

LEPROSY. - PowerPoint PPT Presentation

LEPROSY. A chronic contagious disease primarily affecting the peripheral nerves secondarily involving skin, mucosa of mouth and upper respiratory tract ... – PowerPoint PPT presentation

• A chronic contagious disease primarily affecting the peripheral nerves secondarily involving skin, mucosa of mouth and upper respiratory tract, reticulo-endothelial system, eyes, bones and testes.
• Causative agent Mycobacterium leprae.
• Mode of infection close contact with an open case of leprosy.
• Incubation period average 3-5 years.
•         Lepromatous leprosy.
•        Tuberculoid leprosy.
•        Borderline leprosy.
•        Indeterminate leprosy.
•  Develops in infected persons with low resistance.
•  Clinicaly. The skin, nerves, bones and internal organs are involved in this type.
• Consist of ill-defined multiple erythematos macules, papules, nodules or plaques. The lesions are symmetrically distributed on the face, limbs and trunk. The outer third of eye brows are usually lost
• liver, testicles, lymph nodes and bones may be involved. Eye affection with keratitis, iridocyclitis and iris atrophy.
• Lepromin test is negative, indicating low degree of immunity.
• Develops in persons with good immunity.
• Clinically.
• The skin and peripheral nerves are the only tissues showing clinical evidence of involvement
• . Consist of erythematous or hypopigmented plaques with well-defined edges and anaesthetic dry hairless surface. The lesions are few, large and asymmetrically distributed.
• are early involved in tuberculoid leprosy resulting in wasting and paralysis of the small muscles of the hands and feet, anaesthesia of limbs and trophic changes. In some cases the condition may be limited to peripheral nerves only (neural type). The ulnar nerve is the most commonly affected, less frequently the posterior tibial and the great auricular.
• This type is immunologicaly unstable and usually evolves into one of the previous two polar types. It is intermediate between lepromatous and tuberculoid types and therefore a wide range of pathological and clinical manifestations can be encountered
• Skin lesions. Consist of erythematous macules and plaques, intermediate between lepromatous and tuberculoid in number, size and anaesthesia. They are asymmetrically distributed.
• Lepromin test is weakly positive or negative.
• This type occurs in those whose immunological status has not yet been determined. It is a transitory phase in the disease process. The skin lesions consist of hypopigmented macules which are nonspecific in appearance.
• 1.      Skin smear.
• 2.      Nasal smear.
• 3.      Skin biopsy.
• 4.      Nerve biopsy.
• 5.      Lepromin test.
• 1.      General measures
•         Good nourishing diet.
•         Tonics and vitamins.
• 2.      Chemotherapy
•         SULPHONES dapsone tablets are given usually in a dose of 100 mg/day.
•         Rifampicin is given in a dose of 600 mg/m daily on an empty stomach.
•         CLOFAZIMINE (LAMPRENE) dose is 100mg/m daily.
• various regmins of combined therapy are now recommended to decrease the possibility of emmergence of resistant strains. Combined therapy is particularly recommended in lepromatous leprosy.
• . It depends on the type of leprosy. Tuberculoid leprosy requires treatment for three years or until all signs of activity have seized. Lepromatous leprosy requires treatment for life. In border line leprosy the period of treatment varies betwen 6-9 year and depends on the evolution of the disease.

PowerShow.com is a leading presentation sharing website. It has millions of presentations already uploaded and available with 1,000s more being uploaded by its users every day. Whatever your area of interest, here you’ll be able to find and view presentations you’ll love and possibly download. And, best of all, it is completely free and easy to use.

You might even have a presentation you’d like to share with others. If so, just upload it to PowerShow.com. We’ll convert it to an HTML5 slideshow that includes all the media types you’ve already added: audio, video, music, pictures, animations and transition effects. Then you can share it with your target audience as well as PowerShow.com’s millions of monthly visitors. And, again, it’s all free.

About the Developers

PowerShow.com is brought to you by  CrystalGraphics , the award-winning developer and market-leading publisher of rich-media enhancement products for presentations. Our product offerings include millions of PowerPoint templates, diagrams, animated 3D characters and more.

• World Leprosy Day Template

We are aware that World Leprosy Day is one of the most important events for the welfare of people affected by leprosy. This considering that its main objective is to raise awareness in society about the symptoms of this condition and reduce the stigma against those who suffer from it. Today we want to use the World Leprosy Day template to join this initiative through important presentations dedicated to social welfare in the world.

This world leprosy day template for PowerPoint and Google Slides encompasses an impeccable list of vectors, colors and images inspired by social movements. It comes with 28 editable slides and perfectly compatible with Canva, one of the most popular online platforms for real-time simultaneous ppt editing. This is the time to create a customized presentation to help boost this type of events, do not wait any longer and start now to download this free ppt resource.

Free World Leprosy Day Template for PowerPoint and Google Slides

Main features

• 28 slides 100% editable
• 16:9 widescreen format suitable for all screens
• High quality royalty-free images
• Easy to edit layouts for presenting or printing
• Included resources: charts, graphs, timelines and diagrams
• More than 100 icons customizable in color and size
• Main font: Fjalla One
• Predominant color: Brown

Download this template

Like this design, you can find many more in the category of Google Slides themes and health PowerPoint templates of our web portal. To enter just give a click, then you will be more than ready to search, select and download completely free endless educational contributions created specifically for health, energy and health of humanity.

We use cookies to improve the experience of everyone who browses our website. Cookies Policy

Accept Cookies

How to Record a PowerPoint Presentation

Knowing how to record a PowerPoint presentation with audio and video can provide viewers with an engaging experience. Whether you're creating a tutorial , a lecture, or a business presentation, combining visuals with narration helps convey your message more effectively.

In this guide, we will walk you through the step-by-step recording process in PowerPoint . From setting up your equipment and recording your screen to editing the final video, you'll learn everything you need to know about creating narrated PowerPoint presentations.

Prepare everything

• Presentation . Ensure your slides are complete and in the correct order. Update PowerPoint to the latest version for the best performance and features.
• Microphone . Use a good-quality microphone to record clear audio . A USB or headset microphone is recommended.
• Webcam (Optional) . If you want to include a video of yourself, use a built-in or external webcam.
• Script . Outline what you want to say for each slide. This will help you stay on track during the presentation recording.

How to record a PowerPoint presentation?

1. set up a screen recorder.

Download and install the free screen recording software for Windows from the official website. Launch the video recorder on your computer.

Easy to use free screen recorder for PC. Record desktop, take screenshots, upload the created content to the cloud for easy and fast sharing.

2. Configure settings

Go to " Settings " to set recording preferences .

• In " Video ", choose the desired output quality and format. Make sure the toggles next to " Record mouse movements " and " Animate mouse clicks " are enabled if needed.
• In the " Audio " tab, adjust the sound levels and select the desired input devices.

3. Record your presentation

Click the " Capture video " option in the side menu and select the mode. Choose the entire display if your presentation is in full-screen mode. You can also manually adjust the screen recording area to show the desired content.

Open your PowerPoint and press the F7 hotkey or click the " Rec " button to record the presentation with audio . Navigate through your slides while speaking clearly into the microphone.

Use drawing tools in the presentation recorder to highlight key points during your narration.

If you need to take a break, use the pause button to temporarily stop the recording. When you've completed your presentation, press the F8 hotkey or click " Stop ".

4. Editing the final video

Use the built-in video editor to trim any unwanted parts of the presentation recording. You can also adjust the playback speed, change the format, and resize the video.

If you need to make more changes, you can import your recorded clip into third-party video editing software . Add transitions, effects, background music, or other enhancements as needed.

Save your edited video in the desired location. It is also possible to upload the recording to the cloud and share it via a link .

FAQ on how to record a presentation

PowerPoint screen recording with audio and video is a powerful way to enhance your message and engage your audience. By following the steps outlined in this guide, you can create professional and polished videos that combine your slides with a voice-over .

Whether you're an educator, business professional, or content creator, knowing how to narrate a PowerPoint presentation recording can significantly boost your impact. Remember to practice your delivery and utilize editing tools to refine your final product.

Expert Tech Writer

Like the article? Share it!

National Leprosy Eradication Program (NLEP )

Jun 10, 2013

340 likes | 1.44k Views

National Leprosy Eradication Program (NLEP ). Dr. KANUPRIYA CHATURVEDI. Lesson Objectives. To know about the magnitude of Leprosy problem in India To know about the evolution of Leprosy control/elimination in India To learn about the goals, objectives and strategies for leprosy elimination.

Share Presentation

• single skin lesion paucibacillary
• paucibacillary
• project phase
• medical rehabilitation plan
• leprosy elimination

Presentation Transcript

National Leprosy Eradication Program(NLEP) Dr. KANUPRIYA CHATURVEDI

Lesson Objectives • To know about the magnitude of Leprosy problem in India • To know about the evolution of Leprosy control/elimination in India • To learn about the goals, objectives and strategies for leprosy elimination

Disease Burden • The global registered prevalence of leprosy at the beginning of 2006 was 219,826 cases. There are now only six countries that have still to reach the elimination target of 1 case per 10,000 population, at the national level. • Based on the reports received from all the states and UTs in India for the year of 2008-09 current leprosy situation in the country has been observed as below. • A total of 1.34 lakh new cases were detected during the year 2008-09, which gives Annual New Case Detection Rate (ANCDR) of 11.19 per 100,000 population. This shows ANCDR reduction of 4.36% from 11.70 during 2007-08. • A total of 0.86 lakh cases are on record as on 1st April 2009 giving a Prevalence rate (PR) of 0.72 leprosy cases per 10,000 population. • Detailed information on new leprosy cases detected during 2008-09 indicates the proportion of MB (48.4), Female (35.2), Child (10.1), Visible Deformity (2.8),

Trend of Leprosy Prevalence & Annual New Case Detection (ANCD) Rates in India

Situation of States as per Prevalence- 2001 Vs 2006

National Leprosy Eradication Program Started in 1955 as NLCP with the objective of early detection of cases and treatment with Dapsone monotherapy It was made a centrally sponsored programme in 1980 With the advent of Multi Drug Therapy (MDT) for leprosy the cure rates increased It was changed into eradication programme in 1983 with the objective of eradicating the disease by the end of 2000 The ‘elimination’ was defined as attaining a prevalence Rate (PR) of less than 1 case per 10,000 population

Milestones of leprosy Eradication • 1955 national leprosy control program • 1983 leprosy eradication program ( MDT started) • 1991 World Health Assembly resolution to eradicate leprosy by 2000 AD. • 1993 world bank supported MDT program phase I • 1997 mid term appraisal • 1998-2004 modified leprosy elimination campaign • 2001-2004 NLEP project phase II • 2002 simplified information system • Nationwide evaluation of Project II • NRHM covers NLEP

What does elimination as a public health problem mean? • Reducing the case load to less than 1 case per 10,000 inhabitants • by detecting and curing all cases of leprosy • leading to a reduction in the source of infection and the disease burden in communities • so that leprosy is likely to disappear naturally as it already has from many countries

Leprosy - one of the few diseases which can be eliminated • Leprosy meets the demanding criteria for elimination • practical and simple diagnostic tools: can be diagnosed on clinical signs alone; • the availability of an effective intervention to interrupt its transmission: multidrug therapy • a single significant reservoir of infection: humans.

Rationale for eliminating leprosy • Technically feasible • Prevents patients going on a downward spiral to poverty and destitution due to leprosy related disabilities • Enhances the credibility of and confidence in local health services • Puts into place structures which can be used for other diseases • Releases resources to manage other diseases • Will consign leprosy to history

Highly effective cure available • Multidrug therapy (MDT) • Is a combination of 2 / 3 drugs (clofazimine, rifampicin, dapsone) • Cures patients in 6 months / 12 months depending on form of leprosy • Kills the leprosy bacilli and stops its transmission • Can be delivered under field conditions without special staff and institutions • Is available free of charge from WHO

Project phase II 2001 onwards • Part A: National Plan setting out the project design for the country • Part B: Plan for 8 high endemic states ( Madhya Pradesh, Orissa, Bihar, UP, West Bengal, Uttranchal, Chattisgarh and Jharkhand. • Part C: Plan for remaining 27 states and union territories

Objectives • To achieve elimination of leprosy at national level by the end of the project • To accomplish integration of leprosy services with general health services in the 27 low endemic states • To proceed with integration of services as rapidly as possible in the 8 high endemic states

Elimination strategy • To eliminate the following strategy adopted: • Modified leprosy elimination campaigns ( MLEC): organizing camps for 1 or 2 weeks duration for case detection, treatment and referral • Special action projects for the elimination of leprosy ( SAPEL): initiative for providing MDT services in special difficult to access areas or to neglected population groups

Activities • Early detection of leprosy cases • Intensified health education and public awareness campaigns • Regular treatment of leprosy cases providing multi- drug therapy( MDT) at fixed centres near the patient • Disability prevention and medical rehabilitation

Early detection of leprosy cases • For the field purpose : • Multi-bacillary leprosy is labeled when there are 6 or more skin patches and/or 2 or more nerves affected. Skin smear is positive. • Paubacillary leprosy is labeled when there 5 or less than 5 skin lesions and/or 1 more nerve affected. Skin smear do not show bacilli

Treatment • Rifampicin is given once a month. No toxic effects have been reported in the case of monthly administration. The urine may be coloured slightly reddish for a few hours after its intake, this should be explained to the patient while starting MDT. • Clofazimine is most active when administered daily. The drug is well tolerated and virtually non-toxic in the dosage used for MDT. The drug causes brownish black discoloration and dryness of skin. However, this disappears within few months after stopping treatment. This should be explained to patients starting MDT regimen for MB leprosy. • Dapsone :This drug is very safe in the dosage used in MDT and side effects are rare. The main side effect is allergic reaction, causing itchy skin rashes and exfoliative dermatitis. Patients known to be allergic to any of the sulpha drugs should not be given dapsone.

Treatment contd. • Multibacillary (MB) leprosy • For adults the standard regimen is: Rifampicin: 600 mg once a month Dapsone: 100 mg daily Clofazimine: 300 mg once a month and 50 mg daily Duration= 12 months. • Paucibacillary (PB) leprosy • For adults the standard regimen is: Rifampicin: 600 mg once a month Dapsone: 100 mg daily Duration= six months • Single Skin Lesion Paucibacillary leprosy • For adults the standard regimen is a single dose of: Rifampicin: 600 mg Ofloxacin: 400 mg Minocycline: 100 mg

MDT Dose for Multi-bacillary Leprosy Regimen of three drugs – Rifampicin, Clofazimine and Dapsone for 12 months; first dose of each month to be given in presence of HW.

Multi- drug therapy( MDT) for paubacillary leprosy Regimen of two drugs – Rifampicin and Dapsone for 6 months provided in blister packs

Disability prevention and medical rehabilitation plan Objectives of the rehabilitation plan: • Persons with lepra reactions are adequately managed so as to prevent occurrence of disabilities. • Persons with disabilities due to leprosy are assisted with care and support to prevent worsening of their existing disabilities • Persons with deformities suitable for correction are provided reconstructive surgery services through specialized centers managed by government and voluntary organizations.

Monitoring and evaluation • The implementation of elimination plans in the most endemic countries is closely monitored so as to detect potential problems that might impede its progress and to identify rapid, yet feasible solutions: • promotion of research in the epidemiology of the disease, including modeling • development of computerized databases on leprosy, including data collection, reports and analysis, estimates and predictions of leprosy problem trends • costing and drug requirements for the elimination of the disease • development of simplified tools for data collection, including guidelines and training material, on essential information for the control of leprosy in the most endemic countries

Problems.. • Late detection of patients, many with visible deformities • Poor treatment completion and cure • Fear, prejudice and stigma surrounding leprosy • Limited community awareness and involvement

…but some challenges remain • Leprosy remains a public health problem in 9 States • Poor coverage with MDT services in some difficult to reach areas • Hidden cases who continue to spread the infection • Late detection of patients, many with visible deformities • Poor treatment completion and cure • Fear, prejudice and stigma surrounding leprosy • Limited community awareness and involvement

• More by User

LEPROSY. A chronic contagious disease primarily affecting the peripheral nerves secondarily involving skin, mucosa of mouth and upper respiratory tract, reticulo-endothelial system, eyes, bones and testes. Causative agent: Mycobacterium leprae.

2.93k views • 17 slides

POLIO ERADICATION PROGRAM IN INDIA

POLIO ERADICATION PROGRAM IN INDIA BY P. K. SAHA , M.Sc(Stat), CStat(UK). FELLOW OF THE ROYAL STATISTICAL SOCIETY, UK. CHARTERED STATISTICIAN [email protected]. POLIO ERADICATION PROGRAM IN INDIA. BACKGROUND

1.81k views • 27 slides

Florida GALS Eradication Program

Florida GALS Eradication Program. Methods Development. Objectives. Chemical Control Techniques Molluscicide bait efficacy testing Effective soil drench development Trap Development Most effective trap design Most effective attractants Nematode Detection

358 views • 20 slides

VIEWER DISCRETION IS ADVISED. MAY CONTAIN DISTURBING IMAGES. LEPROSY. Takumi Ohashi. What is it?.

391 views • 7 slides

National Scrapie Eradication Program

National Scrapie Eradication Program. United States Department of Agriculture Animal and Plant Health Inspection Service Veterinary Services Surveillance Response and Preparedness Services Sheep and Goat Health Center. January 2014 Monthly Report

414 views • 26 slides

Leprosy. Dr. Meg- angela Christi Amores. Leprosy. A.k.a. Hansen’s Disease nonfatal, chronic infectious disease caused by Mycobacterium leprae clinical manifestations are largely confined to the skin, peripheral nervous system, upper respiratory tract, eyes, and testes. Etiology.

794 views • 16 slides

Leprosy. Leprosy. Too nasty to show pics. Luke 17 11  As Jesus continued on toward Jerusalem, he reached the border between Galilee and Samaria. 12  As he entered a village there, ten lepers stood at a distance ,. Luke 17

323 views • 16 slides

Current Leprosy Situation

Review Meeting with State Health Secretaries on 11 th & 12 th September, 2012. National Leprosy Eradication Programme (NLEP). Current Leprosy Situation. All States/UTs except Chhattisgarh and Dadra & Nagar Haveli achieved elimination.

319 views • 11 slides

Leprosy. By: RJ & Josh. What is Leprosy?. Leprosy is a infectious disease that is caused by Mycobacterium Leprae . . History. Leprosy has been around for as long as humans have been on Earth. The Disease originated in the countries of China Egypt, India, South Africa. Treatment.

726 views • 11 slides

Leprosy. Kristopher Brevard. 1. What is leprosy?. Ancient disease Causes skin sores, nerve damage and muscle weakness Worsens with time. 2. What causes leprosy?. Mycobacterium leprae Not very contagious Spread through prolonged close contact. Long incubation period. 3.

1.54k views • 14 slides

PF2PAT and tree sample production

PF2PAT and tree sample production. May 9, 2012 Jongseok Lee (Sungkyunkwan University). PAT & tree sample production. PF2PAT + PAT sample production for Fall11 MC : done…90% Tree sample production : done…90%. Exclusion limit with Summer11. nlep + >=2, nlep - >=2, mmmm. isolation, dilpt

150 views • 7 slides

NATIONAL LEPROSY ELIMINATION PROGRAMME 2001 2005

NATIONAL LEPROSY ELIMINATION PROGRAMME 2001 2005. NLEP. STATUS OF NLEP IN UTTRANCHAL. 2004-2005. BACK GROUND. One of the newly formed state. It has got 13 districts out of which 7 districts are high Himalaya, 4 districts are mid Himalaya & 2 districts are plain.

431 views • 24 slides

Effect of tau

Effect of tau. Feb. 19, 2012 Jongseok Lee (Sungkyunkwan University). # of events VS channel (m200). nlep + >=2, nlep - >=2. No cut. Gen2 channels are separated by gen leptons matched 4 reco leptons. nlep + >=2, nlep - >=2. nlep + >=2, nlep - >=2, |mp-mn|/(mp+mn)<0.1.

158 views • 7 slides

4 lepton analysis

4 lepton analysis. March 12, 2014 Jongseok Lee (Sungkyunkwan University). Cut variables for event selection (µµµµ). nlep+>=2, nlep->=2. Cut variables for event selection (µµµµ). nlep+>=2, nlep->=2. Cut variables for event selection (eeee). nlep+>=2, nlep->=2.

259 views • 17 slides

Background estimation for 4leptons

Background estimation for 4leptons. May 14, 2014 Jongseok Lee (Sungkyunkwan University). M(l + l + ) and M(l - l - ). nlep+>=2, nlep->=2, µµµµ. M(l + l + ). M(l - l - ). M(l + l + ) VS M(l - l - ). nlep+>=2, nlep->=2, µµµµ. M(l - l - ). M(l - l - ). side band. side band.

269 views • 17 slides

Staff Updating & Review Meeting Netherlands Leprosy Relief-India

Staff Updating & Review Meeting Netherlands Leprosy Relief-India. R a m n a g a r 8 th & 9 th December 2010 Presented by : Dr. S .N .M i s h r a L.P.A., J h a n s i Zone UP. Field Visits (Supervision days). New changes in NLEP Situation Summary of improvement in functioning of DN

397 views • 27 slides

Leprosy Leprosy (Hansen ‘s disease ) is caused by the acid- fast bacillus Mycobacterium leprae.Unlike other mycobacteria , it does not grow in artificial media or even in tissue culture.Man is the only natural host of M. leprae.

1.59k views • 34 slides

National Scrapie Eradication Program. Fiscal Year 2013 Report October 1, 2012 to September 30, 2013. United States Department of Agriculture Animal Plant Health Inspection Service Veterinary Services Surveillance, Preparedness and Response Services

530 views • 40 slides

ISSUES UNDER NATIONAL LEPROSY ERADICATION PROGRAMME

ISSUES UNDER NATIONAL LEPROSY ERADICATION PROGRAMME. ISSUES. STATUS OF MANPOWER CASE DETECTION & TREATMENT ASHA INVOLVEMENT HIGH ENDEMIC BLOCKS DPMR SERVICES LEPROSY COLONIES FINANCE & AUDIT. STATUS OF MANPOWER.

174 views • 16 slides

NATIONAL LEPROSY ERADICATION PROGRAMME (NLEP), ASSAM

NATIONAL LEPROSY ERADICATION PROGRAMME (NLEP), ASSAM. Epidemiological Status of NLEP, Assam at a glance. Epidemiological Status of NLEP, Assam. Epidemiological Status of NLEP, Assam. Epidemiological Status of NLEP, Assam. Epidemiological Status of NLEP, Assam.

598 views • 25 slides

LEPROSY. Leprosy I Introduction Epidemiology Bacteriology Classification Clinical features. Leprosy II Reactions Diagnosis Treatment Rehabilitation. Introduction. Chronic granulomatous disease Caused by Mycobacterium leprae Mainly involves the peripheral nerves and skin

3.2k views • 57 slides

LEPROSY. HANSEN’S DISEASE DISCOVERED THE ORGANISM IN 1874 CHRONIC INFECTIOUS DISEASE AFFECTING THE COOLER PARTS OF THE BODY. LEPROSY. EXAMPLE SKIN ,MOUTH,RESPIRATORY TRACT,EYES, PERIPHERAL NERVES,SUPERFICIAL LYMPH NODES & TESTIS. LEPROSY.

636 views • 48 slides